Search
Search Results
- Author(s):
- Asch, David A., author
Troxel, Andrea B., author
Stewart, Walter F., author
Sequist, Thomas D., author
Jones, James B., author
Hirsch, AnneMarie G., author
Hoffer, Karen, author
Zhu, Jingsan, author
Wang, Wenli, author
Hodolfski, Amanda, author
Frasch, Antoinette B., author
Weiner, Mark G., author
Finnerty, Darra D., author
Rosenthal, Meredith B., author
Gangemi, Kelsey, author
Volpp, Kevin G., author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2016
- Subject(s):
- Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
Hypercholesterolemia -- drug therapy
Medication Adherence
Motivation
Reimbursement, Incentive
Goals
Physicians, Family
Randomized Controlled Trials as Topic
Humans
United States
- Author(s):
- Meisel, Zachary F., author
Metlay, Joshua P., author
Sinnenberg, Lauren, author
Kilaru, Austin S., author
Grossestreuer, Anne, author
Barg, Frances K., author
Shofer, Frances S., author
Rhodes, Karin V., author
Perrone, Jeanmarie, author
- Publication:
- Philadelphia, PA : Leonard Davis Institute of Health Economics, 2016
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Guidelines as Topic
Personal Narratives as Topic
Practice Patterns, Physicians'
Inappropriate Prescribing -- prevention & control
Randomized Controlled Trials as Topic
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, April 7, 2017
- Subject(s):
- Arthritis, Rheumatoid -- drug therapy
Arthritis, Rheumatoid -- immunology
Immunologic Factors -- therapeutic use
Abatacept -- therapeutic use
Adalimumab -- therapeutic use
Antirheumatic Agents -- adverse effects
Antirheumatic Agents -- therapeutic use
Certolizumab Pegol -- therapeutic use
Cost-Benefit Analysis
Drug Therapy, Combination
Etanercept -- therapeutic use
Immunologic Factors -- adverse effects
Infliximab -- therapeutic use
Interleukin-6 -- antagonists & inhibitors
Janus Kinase Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Rituximab -- therapeutic use
Tumor Necrosis Factors -- antagonists & inhibitors
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, June 8, 2017
- Subject(s):
- Antibodies, Monoclonal -- therapeutic use
Dermatitis, Atopic -- drug therapy
Interleukin-4 Receptor alpha Subunit -- antagonists & inhibitors
Phosphodiesterase 4 Inhibitors -- therapeutic use
Antibodies, Monoclonal -- adverse effects
Cost-Benefit Analysis
Cyclosporine -- therapeutic use
Phosphodiesterase 4 Inhibitors -- adverse effects
Phototherapy
Randomized Controlled Trials as Topic
Treatment Outcome
Humans
United States
- Publication:
- [Boston, Massachusetts] : Institute for Clinical and Economic Review, July 17, 2017
- Subject(s):
- Anabolic Agents -- therapeutic use
Antibodies, Monoclonal, Humanized -- therapeutic use
Osteoporosis, Postmenopausal -- drug therapy
Parathyroid Hormone-Related Protein -- therapeutic use
Anabolic Agents -- adverse effects
Anabolic Agents -- economics
Antibodies, Monoclonal, Humanized -- adverse effects
Antibodies, Monoclonal, Humanized -- economics
Bone Density Conservation Agents -- adverse effects
Bone Density Conservation Agents -- economics
Bone Density Conservation Agents -- therapeutic use
Comparative Effectiveness Research
Diphosphonates -- adverse effects
Diphosphonates -- economics
Diphosphonates -- therapeutic use
Osteoporotic Fractures -- prevention & control
Parathyroid Hormone-Related Protein -- adverse effects
Parathyroid Hormone-Related Protein -- economics
Randomized Controlled Trials as Topic
Teriparatide -- adverse effects
Teriparatide -- economics
Teriparatide -- therapeutic use
Humans
United States
- Author(s):
- Langston, Christopher A., author
- Publication:
- [Washington, D.C.] : Grantmakers in Health, November 19, 2012
- Subject(s):
- Depression -- therapy
Health Promotion
Health Services for the Aged -- economics
Mental Health Services -- economics
Primary Health Care -- methods
Case Management
Cooperative Behavior
Depression -- diagnosis
Financial Support
Foundations
Models, Organizational
Outcome and Process Assessment (Health Care)
Patient Care Team -- economics
Primary Health Care -- economics
Randomized Controlled Trials as Topic
Humans
United States
- Author(s):
- Pearson, Steven D., author
Ollendorf, Daniel A., author
Colby, Jennifer A., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, [2012]
- Subject(s):
- Alzheimer Disease -- diagnosis
Diagnostic Tests, Routine -- methods
Evidence-Based Practice
Insurance Coverage
Biomarkers
Biomedical Research -- methods
Clinical Protocols
Clinical Trials as Topic -- methods
Early Diagnosis
Insurance, Health
Neuropsychological Tests
Outcome Assessment (Health Care)
Patient Outcome Assessment
Policy Making
Practice Guidelines as Topic
Predictive Value of Tests
Prognosis
Randomized Controlled Trials as Topic
Reproducibility of Results
Translational Medical Research -- methods
Humans
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, [2014]
- Subject(s):
- Arteriovenous Malformations -- radiotherapy
Hemangioma -- radiotherapy
Neoplasms -- radiotherapy
Outcome Assessment (Health Care)
Proton Therapy -- instrumentation
Proton Therapy -- methods
Protons -- therapeutic use
Technology Assessment, Biomedical
Certification -- standards
Insurance Coverage
Insurance, Health
Medicare
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Secondary Prevention
Humans
United States
- Author(s):
- Tice, Jeffrey A., author
Ollendorf, Daniel A., author
Pearson, Steven D., author
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, April 15, 2014
- Subject(s):
- Comparative Effectiveness Research
Hepatitis C, Chronic -- drug therapy
Heterocyclic Compounds, 3-Ring -- therapeutic use
Sulfonamides -- therapeutic use
Uridine Monophosphate -- analogs & derivatives
Uridine Monophosphate -- therapeutic use
Antiviral Agents -- economics
Antiviral Agents -- therapeutic use
Cost-Benefit Analysis
Drug Costs
Drug Therapy, Combination
Genotype
Hepatitis C -- economics
Hepatitis C -- genetics
Heterocyclic Compounds, 3-Ring -- adverse effects
Heterocyclic Compounds, 3-Ring -- economics
Insurance Coverage
Interferon-alpha -- therapeutic use
Oligopeptides -- therapeutic use
Polyethylene Glycols -- therapeutic use
Proline -- analogs & derivatives
Proline -- therapeutic use
Protease Inhibitors -- economics
Protease Inhibitors -- therapeutic use
Randomized Controlled Trials as Topic
Ribavirin -- therapeutic use
Sulfonamides -- adverse effects
Technology Assessment, Biomedical
Treatment Outcome
Uridine Monophosphate -- adverse effects
Uridine Monophosphate -- economics
Value-Based Purchasing
Humans
United States
- Publication:
- [Boston, MA] : Institute for Clinical and Economic Review, December 2014
- Subject(s):
- Comparative Effectiveness Research
Diabetes Mellitus, Type 2 -- drug therapy
Disease Management
Blood Glucose -- analysis
Blood Glucose -- metabolism
Dipeptidyl-Peptidase IV Inhibitors -- therapeutic use
Drug Therapy, Combination
Hemoglobin A, Glycosylated -- analysis
Hypoglycemic Agents -- administration & dosage
Hypoglycemic Agents -- therapeutic use
Insulin -- therapeutic use
Metformin -- administration & dosage
Metformin -- therapeutic use
Monitoring, Ambulatory
Randomized Controlled Trials as Topic
Receptors, Glucagon -- agonists
Sulfonylurea Compounds -- administration & dosage
Sulfonylurea Compounds -- therapeutic use
Treatment Outcome
Humans
New England
United States
